U.S. Market Wrap

Yuhan (000100.KS) Q1 2026: Net Profit +134% on Non-Op Windfall

Yuhan (000100.KS) Q1 2026: Net Profit +134% on Non-Op Windfall *Equity method gains and financial income power the headline profit surge; lazertinib advances to five-market approval while core operati

Foreign Investors Trade $4.4B via Korea's Omnibus Accounts

Forest Partners Backs Battery 'Foundry' JR Energy Solution at ₩100 Billion in EV-Downturn Bet

Forest Partners, a Seoul-based private equity firm, has invested more than ₩10 billion ($7.3 million) in JR Energy Solution, a battery contract manufacturer fou

Samsung Electro-Mechanics, LG Innotek Set for Q2 Record as AI Substrate Squeeze Deepens

SEMCO Q2 operating profit seen +79% to KRW380.7B; FC-BGA demand outstrips supply by over 50% with no new capacity before 2028. LG Innotek FY26 OP est. KRW1.1T.

Overnight Lines Return as CJ Olive Young Opens Second U.S. Outpost Near Beverly Hills

CJ Olive Young opened its second U.S. store at Westfield Century City on June 13, 2026, as the USD 2 billion U.S. K-beauty market grew 37% in 2025 — the retailer now eyes a third California location a

Hyundai Motor Group Advances to 11.8% U.S. Market Share Through April as Hybrids Absorb Tariff Shock

Hyundai Motor Group claimed 11.8 percent of the U.S. auto market in the first four months of 2026, up one percentage point year-on-year, as hybrid sales surged 66 percent in January and a bilateral trade deal cut the tariff rate from 25 to 15 percent.

GS (078930.KS) Q1 2026: Profit Surges 3.5× on Caltex Equity Boom

GS Holdings (078930.KS) Q1 2026 controlling shareholder net income surged 3.5× YoY to ₩723.2B, driven by one-off inventory gains from a Hormuz-driven crude spike amplifying GS Caltex's equity contribution.

Shinhan Folds Its Super-App Into SOL Bank as Korea's Lenders Reignite the Platform War

Shinhan Financial Group (055550.KS), Korea's second-largest financial holding company by assets, will relaunch its all-in-one "Super SOL" platform on June 17, but the new version quietly concedes that its first attempt missed. Rather than maintain a standalone super-app, Shinhan is embedding card, securities and insurance functions directly into SO

K-Biotech's Animal-Free Pivot: Samsung Biologics and Peers Race to Meet New FDA and EU Drug Rules

The EU and FDA are converging on a phaseout of animal testing in drug development, creating a new competitive arena where Samsung Biologics and a cohort of Korean biotech firms are building organoid and AI capabilities to stay ahead.

Hanwha Solutions (009830.KS) Q1 2026: ₩92.6B Operating Swing as Chemicals Rebound, Qcells Profit Halves

Hanwha Solutions posted consolidated operating profit of ₩92.6 billion in Q1 2026, a 205.5% year-on-year surge from ₩30.3 billion, ending a two-year operating loss streak that had consumed ₩1.37 trill

SK Hynix Eyes August U.S. ADR Debut, Eyes USD 14 Billion as HBM Crown Meets Capital Markets

SK Hynix (000660.KS), the world's second-largest memory chipmaker and dominant supplier of high-bandwidth memory to AI data centers, is targeting an American De

Daeduck (008060.KS) Q1 2026: AI Substrates Flip Profit to ₩51.3B

KOSPI's 109% Rally Masks a K-Shaped Market: 31% of Stocks at New Lows as Two Chipmakers Claim 72% of Gains

As the KOSPI hits record highs near 8,800, market breadth has collapsed: 31% of listed stocks are at 52-week lows while Samsung and SK Hynix alone account for 72% of year-to-date gains.